European - Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: To provide bulk and cohesive properties.

In the world of modern medicine, the tablet is the undisputed king. It is the default delivery system for the vast majority of active pharmaceutical ingredients (APIs). Yet, behind every unassuming white disc lies a complex engineering challenge: how do you ensure that a powder becomes a solid, survives the journey in a bottle, and then dissolves perfectly inside the human body? European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: Delayed-release formulations designed to resist gastric fluid breakdown and release the active drug inside the intestinal fluid. They are typically coated with acid-resistant polymers. : To provide bulk and cohesive properties

This test measures the tablet's ability to withstand abrasion during packaging and transport. A sample of tablets is rotated in a drum for a set time (usually 100 rotations). Yet, behind every unassuming white disc lies a

According to the monograph, tablets are intended for oral administration. Some are swallowed whole, some after chewing, some are dissolved or dispersed in water before administration, and others are intended to be retained in the mouth to release the active substance.

One of the most vital safety checks, this test ensures that every individual tablet contains the intended amount of API within strict tolerances. Compliance can be demonstrated via:

According to the , tablets are defined as solid preparations containing a single dose of one or more active substances .